Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2003
05/01/2003WO2003035046A2 Salts formed of an at1-receptor antagonist and a cardiovascular agent
05/01/2003WO2003035029A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/01/2003WO2003035027A1 Chewable tablet containing lysine
05/01/2003WO2003034996A2 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2003034978A2 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives
05/01/2003WO2003034837A1 Dosage system & dosage vehicle therefor
05/01/2003WO2003026637A3 Dosage form for treatment of diabetes mellitus
05/01/2003WO2003020283A3 Method for treating diabetic retinopathy
05/01/2003WO2003013578A8 Omoxin agonists and antagonists for use in the treatment of metabolic disorders
05/01/2003WO2003008412A3 Hetero-bicyclic crf antagonists
05/01/2003WO2003004040A3 Dietetic preparation with hypocholesterolemic activity
05/01/2003WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2002094247A3 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
05/01/2003WO2002090352A3 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
05/01/2003WO2002085293A3 Production of alpha-lipoic acid
05/01/2003WO2002083734A3 Modified calcitonin
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002074292A3 Hormone replacement therapy
05/01/2003WO2002058685A3 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
05/01/2003WO2002048148A3 Pyrazolopyridine derivatives
05/01/2003WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/01/2003WO2002005834A3 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
05/01/2003WO2002005830A3 Extracts from crassulacean acid metabolism (cam) mechanism plants and uses thereof
05/01/2003US20030083642 Devices and methods for the restoration of a spinal disc
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083465 Protein for use in treatment and prevention of angiogenesis
05/01/2003US20030083363 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
05/01/2003US20030083357 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
05/01/2003US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/01/2003US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
05/01/2003US20030083337 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083329 Biologically active 4H-benzo [1,4] oxazin-3-ones
05/01/2003US20030083315 Benzimidazole derivatives for treating an inflammatory disease, an allergy disease, a respiratory disease, a cardiovascular disorder or a bone disorder
05/01/2003US20030083310 Process for producing an iron-dextran compound, iron-dextran compound produced according to said process, pharmaceutical composition for prophylaxis or treatment of iron-deficiency and use of said compound for the preparation of a parenterally administrable pharmaceutical composition
05/01/2003US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
05/01/2003US20030083272 Sense mrna therapy
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030083259 Use of a peptide
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082286 Low calorie; sugar replacement
05/01/2003US20030082247 Obesity inhibitory materials
05/01/2003US20030082240 Porous sphere of calcium carbonate
05/01/2003US20030082207 Method of using HIV protease inhibiting compounds
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082184 Uses of mammalian cytokine; related reagents
05/01/2003US20030082179 Complexing antibody with poarathyroid hormone
05/01/2003US20030082176 Therapy for metabolism disorders
05/01/2003US20030082169 System and method for the pretreatment of the endplates of an intervertebral disc
05/01/2003US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions
05/01/2003US20030082155 Antidiabetic agents; cell differentiation of stem cells
05/01/2003US20030079747 Method of decreasing fasting sugars and weight gains in diabetic patients
05/01/2003US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2464981A1 Quinoline compound
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464331A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
05/01/2003CA2464277A1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
05/01/2003CA2464256A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
05/01/2003CA2464111A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003CA2463923A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same
05/01/2003CA2463803A1 Biphasic mixtures of glp-1 and insulin
05/01/2003CA2463758A1 Salts formed of an at1-receptor antagonist and a cardiovascular agent
05/01/2003CA2463311A1 Androgen receptor modulators and methods of use thereof
05/01/2003CA2463226A1 Acetic acid derivatives
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2463043A1 Combination of liponic acid and glutamine in food and pharmaceutical products
05/01/2003CA2462250A1 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives
05/01/2003CA2461661A1 Use of histamine to treat liver disease
05/01/2003CA2461543A1 Sperm factor sequences
04/2003
04/30/2003CN1414961A Substituted oximes and hydrazones as neurokinin antagonists
04/30/2003CN1414956A Substituted piperazine derivatives as MIP inhibitors
04/30/2003CN1414953A Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and 5-hydroxytryptamine
04/30/2003CN1414952A Heterocyclic compounds having sulfonic acid
04/30/2003CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions
04/30/2003CN1414864A Adhesive particle DNA constructs and method of making and using the same
04/30/2003CN1414862A Antidiabetic formulation and method
04/30/2003CN1414854A Phosphonate compounds
04/30/2003CN1414852A Novel composition and use thereof
04/30/2003CN1414834A Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein
04/30/2003CN1414012A Olive acid lactose conjugated material and its preparation method and use
04/30/2003CN1413723A Method for extracting medicine from bluish dogbane
04/30/2003CN1413716A Prescription of weight-reducing and health-care preparation
04/30/2003CN1413706A Elmination of toxicant and fat-lowering capsule and its preparation technology
04/30/2003CN1413701A Drug for treating diabetes
04/30/2003CN1413673A Medicine for treating diabetes and its preparation method
04/30/2003CN1413670A Wax gourd weight-reducing liquid and its making method
04/30/2003CN1413644A Alfalfa root medicinal extract
1 ... 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 ... 1298